Compositions and methods for treating respiratory syncytial virus infection
Briefly described, embodiments of the present disclosure relate to isolated polypeptides useful for treatment of respiratory syncytial virus, and to methods and compositions for treating respiratory syncytial virus.
1. An isolated polypeptide comprising an amino acid sequence selected from the group consisting of: SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, and SEQ ID NO:10.
2. The isolated polypeptide of claim 1 , wherein the amino acid sequence is SEQ ID NO:2.
3. The isolated polypeptide of claim 1 , wherein the amino acid sequence is SEQ ID NO:7.
4. The isolated polypeptide of claim 1 , wherein the isolated polypeptide consists essentially of: an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, and SEQ ID NO:10.
5. A composition comprising a micelle having a lipid layer and a core, wherein the core comprises a first polypeptide, and wherein the first polypeptide comprises an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, and SEQ ID NO:10.
6. The composition of claim 5 , wherein the amino acid sequence is SEQ ID NO:7 or SEQ ID NO:2.
7. The composition of claim 5 , wherein the first polypeptide consists essentially of an amino acid sequence selected from the group consisting of: SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, and SEQ ID NO:10.
8. The composition of claim 5 , wherein the lipid layer comprises amine-PEG-PE.
9. The composition of claim 5 , wherein the lipid layer comprises amine-PEG-PE, methoxy-PEG-PE, and DSPC, and wherein the first polypeptide comprises SEQ ID NO:7.
10. The composition of claim 9 , wherein the micelle is prepared with about 20% amine-PEG-PE, about 20% methoxy-PEG-PE, and about 60% DSPC.
11. The composition of claim 5 , further comprising a coating, wherein the coating comprises a second polypeptide, wherein the second polypeptide comprises an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, and SEQ ID NO:10.
12. The composition of claim 11 , wherein the first polypeptide comprises SEQ ID NO:2 and the second polypeptide comprises SEQ ID NO:7.
13. The composition of claim 11 , wherein the first polypeptide consists essentially of SEQ ID NO:7 and the second polypeptide consists essentially of SEQ ID NO:2.